Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
0.7764
+0.0190 (2.51%)
At close: Oct 28, 2026, 4:00 PM EDT
0.7800
+0.0036 (0.46%)
Pre-market: Oct 29, 2026, 6:08 AM EDT
Ocugen Market Cap
Ocugen has a market cap or net worth of $263.29 million as of October 28, 2026. It is the 18,947th most valuable company in the world and the 3,337th biggest in the United States. Its market cap has decreased by 45.96% in one year.
Market Cap
263.29M
Enterprise Value
251.22M
1-Year Change
-45.96%
Global Rank
Country Rank
#3,337 United States
Category
ChartMarket Cap Chart
Since September 30, 2019, Ocugen's market cap has increased from $32.75M to $263.29M, an increase of 703.94%. That is a compound annual growth rate of 34.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 263.29M | -37.56% |
| Dec 31, 2025 | 421.63M | 79.79% |
| Dec 31, 2024 | 234.51M | 59.00% |
| Dec 29, 2023 | 147.49M | -48.17% |
| Dec 30, 2022 | 284.55M | -68.60% |
| Dec 31, 2021 | 906.30M | 205.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vogenx | 259.22M |
| SAB Biotherapeutics | 258.40M |
| Q32 Bio | 257.51M |
| Lineage Cell Therapeutics | 252.91M |
| Fate Therapeutics | 252.82M |
| Abeona Therapeutics | 251.61M |
| Rocket Pharmaceuticals | 251.38M |
| Cabaletta Bio | 249.23M |